Upcoming Conferences
Pharsight makes strong contribution at PAGE 2012.
COPD exposure-response analysis to be presented at American Thoracic Society.
View Abstracts
Software Products Products
New QRPEM algorithm released for Phoenix NLME - faster, more accurate than existing mixed effects modeling methods due to a vastly improved sampling method. Learn more
With Phoenix Connect, get increased support for integrated workflows that include third party software, such as NONMEM, SAS, S+ or R, in Phoenix Connect, allowing Phoenix to more fully support pharmacometrics workflows. Learn more
Consulting Services Services
Our 40+ scientists apply quantitative analysis and predictive models of diseases, drugs and clinical trials to support strategic decisions and new drug submissions.
Therapeutic Focus: HCV - Pharsight experts to provide hands-on training on HCV modeling and simulation at UMB's Center for Translational Medicine
Learn More/Register
Client Testimonial: Modeling and simulation for rare genetic diseases. Read More...
Pharsight software products and services facilitate improved productivity and strategic decision making in drug development.
Since the company’s founding in 1995, our goal remains to help customers reduce the time, cost and risk of drug development. With more than 1200 customers worldwide, Pharsight products and services are used by all of the world’s top 50 drug development organizations. Pharsight software improves the value and availability of preclinical and clinical program data for PK/PD modeling, analysis, data management, and reporting. Pharsight Consulting Services is the world’s largest and most experienced pharmacometric consulting group, a global team of experts dedicated to supporting strategic development decisions and submission-ready analyses for new drug approval.